Publications

5808 Results

Current trials and future directions of the Southwest Oncology Group (SWOG) Breast Cancer Committee.

Authors
CK Osborne
Journal / Conference
Cancer 74(3):1135-1138
Year
1994

Breast cancer outcome and predictors of outcome: Are there age differentials?

Authors
KS Albain;DC Allred;G Clark
Journal / Conference
Journal of the National Cancer Institute Monographs 16:35-42
Year
1994

SWOG 8609 - a phase II trial of teniposide (VM-26) as therapy for extensive small cell lung cancer (SCLC)

Authors
V Canfield;P Grozea;J Crowley;R Livingston
Journal / Conference
Lung Cancer 11(Suppl.1):102(#389)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-8609

Phase II trial of dimethyl triazeno imidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.

Authors
RM Bukowski;CM Tangen;RF Peterson;SA Taylor;JJ Rinehart;HJ Eyre;SE Rivkin;T Fleming;JS Macdonald
Journal / Conference
Cancer 73(5):1505-1508
Year
1994
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8411

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study

Authors
GB Selby;C Upchurch;J Townsend;HJ Eyre
Journal / Conference
Cancer Chemotherapy and Pharmacology 34(2):179-180
Year
1994
Research Committee(s)
Brain
Study Number(s)
SWOG-8834

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma: A Southwest Oncology Group study.

Authors
JA Kish;M Wolf;ED Crawford;JT Leimert;A Bueschen;JR Neefe;RC Flanigan
Journal / Conference
Cancer 74(3):916-919
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8926

Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphoma: A prospective Southwest Oncology Group (SWOG) trial.

Authors
TP Miller;TM Grogan;S Dahlberg;CM Spier;RM Braziel;PM Banks;K Foucar;CR Kjeldsberg;N Levy;BN Nathwani;B Schnitzer;RR Tubbs;ER Gaynor;RI Fisher
Journal / Conference
Blood 83(6):1460-1466
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067), SWOG-8819

Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group

Authors
VK Sondak;KJ Kopecky;PY Liu;WS Fletcher;WH Harvey;LR Laufman
Journal / Conference
Anti-Cancer Drugs 5:147-150
Year
1994
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8754

The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma: A disease with diverse molecular and immunophenotypic findings

Authors
CP Leith;CL Willman;CM Spier;TP Miller;TM Grogran
Journal / Conference
Diagnostic Molecular Pathology 3(3):178-183
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Cisplatin versus carboplatin in advanced ovarian cancer: An economic analysis

Authors
DS Alberts;EV Hannigan;R Cannetta;R O'Toole;VK Malviya;EA Surwit;WA Nahhas;CJ Jolles;J Jacobs;S Pashko
Journal / Conference
Pharmacy and Therapeutics 19(7):692-706
Year
1994
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412